KLOW Blend 60mg — Vial Spec, Reconstitution Math & COA

Composition and Availability of the KLOW Blend 60mg Specification

A 60mg vial of KLOW blend contains a precise stoichiometric combination of four synthesized peptide sequences: BPC-157, TB-500 (Thymosin Beta-4 active fragment), GHK-Cu (Copper Tripeptide-1), and KPV (Lysine-Proline-Valine, an alpha-MSH C-terminal tripeptide fragment). This multi-target matrix is formulated specifically for cell culture assays, tissue-engineering models, and biochemical research evaluating synergistic cellular signals, extracellular matrix remodeling, and inflammatory pathway modulation.

Principal investigators and laboratory managers select a total mass size of 60mg when running multi-plate cellular assays or longitudinal rodent studies that require a continuous supply of identical lot-matched material. Utilizing a unified, pre-mixed peptide matrix eliminates inter-vial reconstitution variance across individual components and streamlines pipette dosing across extensive experimental replicates.

Please note: PX1 Research manufactures and standardizes this high-yield quadri-peptide combination under our flagship high-density format, available as the KLOW Blend 80mg vial. If your laboratory requires specific batch allocations, custom fill volumes, or alternative total mass configurations such as 60mg, these can be requested through our institutional supply channels. Laboratories seeking immediate off-the-shelf dispatch can inspect our full catalog of research peptides for currently stocked vial sizes.

Molecular Mechanisms of the Four KLOW Components in Preclinical Assays

To understand the experimental utility of the KLOW matrix, research teams must evaluate the individual mechanisms of action verified in peer-reviewed literature. BPC-157 is a pentadecapeptide investigated in vitro for its influence on VEGFR2 expression, focal adhesion kinase (FAK) phosphorylation, and the stimulation of nitric oxide synthase pathways in endothelial cells. Animal models suggest BPC-157 accelerates cell migration and angiogenesis in compromised tissue matrices.

TB-500 represents an active domain of Thymosin Beta-4, a major G-actin sequestering peptide. In preclinical cell assays, TB-500 exhibits profound effects on actin polymerization, cell migration, and dermal fibroblast motility. GHK-Cu is a naturally occurring copper-binding tripeptide that modulates gene expression related to collagen synthesis, metalloproteinase activity, and antioxidant enzyme regulation in dermal and musculoskeletal models.

Completing the matrix, KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). In vitro studies indicate KPV acts as a potent inhibitor of NF-κB nuclear translocation, downregulating pro-inflammatory cytokine cascades without exhibiting systemic hormonal receptor activation. When combined in a single 60mg vial, these four compounds enable investigators to study cross-talk between structural extracellular matrix synthesis and immune response modulation.

Reconstitution Mathematics for a 60mg Mass Matrix

Reconstituting a 60mg total peptide mass requires precise volumetric calculations to achieve predictable working concentrations for micro-pipetting. Because the lyophilized cake contains a high total solute mass, researchers must account for liquid volume displacement and ensure total dissolution before withdrawing working aliquots. Using an interactive reconstitution calculator is recommended to verify microgram-per-microliter metrics prior to assay deployment.

When adding 1.0 mL of diluent (e.g., Bacteriostatic Water or Sterile Normal Saline) to a 60mg lyophilized vial, the resulting stock concentration is exactly 60 mg/mL, which translates to 60 µg per microliter (µL). This high concentration is ideal for low-volume dosing in automated cell culture platforms or concentrated primary stock creation.

When adding 2.0 mL of diluent to a 60mg vial, the final stock concentration yields 30 mg/mL (30 µg/µL). Adding 3.0 mL of diluent produces a final concentration of 20 mg/mL (20 µg/µL). For routine micro-pipetting, a 2.0 mL or 3.0 mL diluent addition provides lower fluid viscosity and reduces volumetric delivery error when handling small micro-aliquots in 96-well or 24-well plate formats.

Diluent Selection and Solvent Compatibility Protocols

Selecting the appropriate solvent is critical when reconstituting high-mass peptide mixtures like the 60mg KLOW blend. For multi-dose laboratory assays stored over extended periods at 4°C, Bacteriostatic Water containing 0.9% USP benzyl alcohol is the standard diluent. The antimicrobial preservative prevents bacterial proliferation during repeated vial septum punctures over a standard 28-day laboratory window.

For downstream applications sensitive to benzyl alcohol—such as primary cell culture, delicate organoid models, or specific in vitro enzymatic assays—sterile 0.9% Sodium Chloride (Normal Saline) or sterile Phosphate-Buffered Saline (PBS, pH 7.4) should be utilized. When using unpreserved aqueous diluents, the reconstituted solution must be aliquoted immediately into single-use polypropylene tubes and frozen to eliminate the risk of microbial contamination.

Due to the presence of GHK-Cu in the KLOW matrix, researchers should avoid highly acidic diluents or strong chelating agents (such as EDTA) in the reconstitution buffer. Chelating compounds can strip the bound copper (II) ion from the GHK tripeptide core, altering the thermodynamic structure and biological activity of the molecular complex.

Aliquot Planning and Thermal Stability Management

Lyophilized peptide vials are structurally sensitive to moisture, temperature fluctuations, and repeated freeze-thaw cycles. Upon receiving a 60mg KLOW vial, the dry cake should be stored in a dedicated laboratory freezer at -20°C for short-term projects or -80°C for long-term storage, protected from direct light exposure.

Once reconstituted, high-concentration peptide solutions undergo gradual peptide bond hydrolysis if maintained in liquid state at room temperature. To prevent degradation, the primary stock solution should be divided into single-use micro-aliquots using sterile, low-binding polypropylene microcentrifuge tubes. This procedure isolates working samples and prevents the degradation associated with repeated thermal cycles.

When working with aliquots frozen at -20°C or -80°C, thaw the required micro-tube at 4°C or on wet ice immediately prior to administration in the assay protocol. Avoid rapid thermal warming in water baths above 37°C, as localized thermal spikes can denature secondary peptide conformations and accelerate peptide cleavage.

Lot-Matched Certificate of Analysis (COA) Verification

Every batch of peptide matrix synthesized for research applications must undergo rigorous analytical verification before laboratory dispatch. Assessing a complex multi-peptide mixture requires high-performance analytical tools capable of resolving individual peptide peaks simultaneously. Researchers can verify batch specifications directly through the PX1 COA verification database.

High-Performance Liquid Chromatography (HPLC) is performed on every lot to determine chemical purity. For multi-component blends like KLOW, the chromatogram must exhibit crisp, fully resolved chromatographic peaks corresponding to each individual peptide sequence, with a combined total chemical purity exceeding 98.0%. Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass of each component (BPC-157, TB-500 fragment, GHK-Cu, and KPV).

Furthermore, quantitative Chromogenic Reagent Endotoxin Testing (LAL assay) is conducted on all finished vials. PX1 Research enforces strict limits, ensuring endotoxin levels remain consistently below <0.01 EU/mg. This guarantees that cell culture responses are driven purely by peptide-receptor interactions rather than lipopolysaccharide (LPS) induced inflammatory artifacts.

Comparative Analysis: KLOW Blend vs. Single-Peptide Assays

When designing experimental protocols, principal investigators must evaluate whether a composite blend or isolated single-peptide sequences best suit their hypothesis. The KLOW combination simultaneously activates multiple physiological cascades—angiogenic pathways via BPC-157 10mg, cytoskeletal actin dynamics via TB-500 10mg, gene-mediated tissue remodeling via GHK-Cu 50mg, and NF-κB suppression via KPV 10mg.

For broad phenotypic screening or complex tissue regeneration models, using the combined 60mg KLOW matrix reduces total preparation time and standardizes component ratios across experimental groups. Conversely, if an assay requires isolating the exact dose-response curve of a single target receptor, individual baseline reagents should be ordered separately. For additional cross-reference studies, consult our extensive peptide research library.

Sizing Strategy: Evaluating 60mg vs. Alternative Mass Configurations

Selecting the optimal vial size depends directly on your laboratory's project scale and handling workflow. A single 60mg vial provides substantial mass, making it highly cost-effective for medium-to-large research protocols. However, if an assay protocol calls for sporadic, low-frequency testing, opening a large 60mg vial may risk solvent degradation before the full volume is consumed.

For smaller exploratory studies, smaller fill sizes or individual component vials prevent material waste. For large-scale university core facilities, high-throughput commercial screening, or ongoing animal study lines, ordering larger standard formats like our 80mg variant—or setting up a dedicated supply agreement—ensures consistent lot uniformity across extended experimental timelines. Institutional buyers can review custom logistics and volume tiers via our wholesale account platform.

PX1 Research Quality Assurance and Domestic Supply Chain

PX1 Research operates as a primary USA-based research peptide manufacturer and distributor dedicated strictly to supporting laboratory scientific inquiry. All peptide sequences are synthesized using advanced solid-phase peptide synthesis (SPPS) technology inside state-of-the-art, ISO 17025 accredited and GMP-compliant facilities.

By maintaining complete domestic oversight of synthesis, purification, lyophilization, and analytical testing, PX1 eliminates the quality risks associated with unverified overseas sourcing. Orders ship directly from our climate-controlled fulfillment centers in California and Arizona, featuring same-day dispatch for orders finalized Monday through Friday before 3:00 PM EST. Every shipment includes lot-matched analytical documentation ensuring uncompromising quality for your laboratory research.